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Subtilisins  and  other  serine  proteases  are  extensively  used  in  the  detergent,  leather  and  food  industry,  and
frequently  under  non-physiological  conditions.  New proteases  with  improved  performance  at  extreme
temperatures  and  in  the  presence  of  chemical  additives  may  have  great  economical  potential.  The  increas-
ing  availability  of genetic  sequences  from  different  environments  makes  homology-based  screening  an
attractive  strategy  for discovery  of new  proteases.  A  prerequisite  for  large-scale  screening  of  protease-
encoding  sequences  is  an  efﬁcient  screening  procedure.  We  have  developed  and implemented  a  screening
procedure  that  encompasses  cloning  of candidate  sequences  into  multiple  expression  vectors,  cytoplas-
mic  expression  in E.  coli,  and a casein-based  functional  screen.  The  procedure  is  plate-format  compatible
and  can  be  completed  in only  four days,  starting  from  the  gene  of  interest  in  a  suitable  cloning  vector.
The  expression  vector  suite  includes  six  vectors  with  combinations  of  maltose-binding  protein  (MBP)  or
the  small  ubiquitin-related  modiﬁer  (SUMO)  for  increased  solubility,  and  polyhistidine  tags  for  down-
stream  puriﬁcation.  We  used  enhanced  green  ﬂuorescent  protein  and  four  Bacilli  subtilisins  to validate  the
screening  procedure  and  our results  show  that proteins  were  expressed,  soluble  and active.  Interestingly,
the  highest  activities  were  consistently  achieved  with  either  MBP  or SUMO  fusions,  thus  demonstrating
the  merit  of  including  solubility  tags.  In conclusion,  the  results  demonstrate  that our  approach  can  be
used  to efﬁciently  screen  for new  subtilisins,  and  suggest  that the  approach  may  also  be  used  to screen
for  proteins  with  other  activities.
©  2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Proteases are proteolytic enzymes that have great industrial,
herapeutic and academic value because of their ability to degrade
roteins and peptides (reviewed in Li et al., 2013). In particular,
erine proteases have broad applications in the detergent, leather
nd food industry, due to their broad substrate speciﬁcity and their
ctivity at neutral to alkaline pHs (reviewed in Gupta et al., 2002).
he industrial conditions under which these proteases are applied
ay  be non-physiological, and include high temperatures, cocktails
f detergents and other chemical additives. Discovery and devel-
pment of proteases that are applicable to industry have a great
conomic potential, and both sequence- and function-based dis-
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E-mail addresses: Gro.Bjerga@uni.no (G.E.K. Bjerga), Hasan.Arsin@uib.no
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ttp://dx.doi.org/10.1016/j.jbiotec.2016.02.009
168-1656/© 2016 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
covery can be used (exampliﬁed in Biver et al., 2013; Kwon et al.,
2011). These approaches require a robust production line, which
should include molecular cloning and recombinant expression, and
functional screening procedures tailored to the relevant proteases
(Kwon et al., 2011; Sroga and Dordick, 2002).
Subtilisin-like serine proteases are extensively used in industry,
mainly in detergents, and according to a HERA-report,1 the Euro-
pean Union used about 1000 tons of pure subtilisins in 2002. These
proteases are well represented among species of Bacilli, are active
at an alkaline pH range, and show speciﬁcity towards aromatic or
hydrophobic residues (Groen et al., 1992). Subtilisins are involved
in nutritional regulation in their native hosts and are frequently
secreted. They are produced as inactive precursor proteins called
pre-pro-proteins or zymogens consisting of a leader sequence that
direct their export, a pro-sequence and the catalytic domain. The
1 Human & Environmental Risk Assessment on ingredients of household cleaning
products, Edition 2.0 February 2007.
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Fig. 1. Schematic representation of the expression vector suite.
Upon restriction-ligation in the FX-cloning regime the gene of interest is replacing
the  ccdB counterselection gene in expression vectors. All vectors, named p1, p2, p3,
p12, p7 and p6, contain his-tags, either N-terminally (decahistidine) or C-terminally
(hexahistidine). In addition, four of the vectors contain the MBP and SUMO solubility
partners as fusions to the N-terminies of the protease sequences. Triangles showG.E.K. Bjerga et al. / Journal o
ro-sequence acts as an inhibitor and as a molecular chaperone to
uide correct folding of the active enzyme both in vivo and in vitro
Ikemura et al., 1987; Ohta et al., 1991; Zhu et al., 1989).
Autoproteolytic maturation poses a challenge for heterologous
roduction, but subtilisin-like proteases have been successfully
roduced in E. coli by periplasmic expression (Ikemura and Inouye,
988; Ikemura et al., 1987). Increased solubility and yield have
een achieved with solubility tags, such as the maltose-binding
rotein (MBP2) (Bedouelle and Duplay, 1988; di Guan et al., 1988;
apust and Waugh, 1999 Kapust and Waugh, 1999), fused to the N-
erminus of active serine proteases (Kwon et al., 2011; Sakaguchi
t al., 2008). For identiﬁcation and downstream puriﬁcation of
ature subtilisin-like proteases, they are often expressed in fusion
o C-terminal afﬁnity tags, such as polyhistidine (his) (Ghasemi
t al., 2012; Hu et al., 2013; Sroga and Dordick, 2002).
In this study, we have developed a screening procedure for rapid
nd efﬁcient identiﬁcation of functional subtilisins. The procedure
ses E. coli as host, implements a versatile cloning system tailored to
roteases, followed by recombinant expression in the cytosol, and
irect activity screening of lysates using ﬂuorescein isothiocyanate
FITC)-conjugated casein as substrate. The cloning system allows
xpression of candidate proteases with terminal his-tags for puriﬁ-
ation, optionally in combination with N-terminal fusions to MBP
nd the small ubiquitin-related modiﬁer (SUMO) for improved sol-
bility. To validate our approach we have tested four homologous
acilli subtilisins, and show that our screening procedure effectively
xpresses and detects active, recombinant subtilisins.
. Material and methods
.1. Construction of a tailored vector suite
A tailored suite of six different vectors were designed and
onstructed for the recombinant expression of proteases (Fig. 1,
able 1). p1-p3 vectors contain N-terminal decahistidine tags, and
12, p6 and p7 vectors contain C-terminal hexahistidine tags. The
reference for the C-terminal hexahistidine to decahistidine was
ased on experimental data showing better yields of expression
nd solubility of eGFP with shorter tag (data not shown). The p2
nd p3 vectors were generated by introducing genes encoding the
BP  and SUMO fusion partners, respectively, between the exist-
ng His-tag and HRV 3C protease (3C) protease site of the p1 vector
Table 1) (Geertsma and Dutzler, 2011). The p12 vector was  con-
tructed based on p5 (Table 1) (Geertsma and Dutzler, 2011), where
he 3C cleavage site and decahistidine tag was replaced with a hex-
histidine tag. Vectors p6 and p7 were constructed by introducing
he above-mentioned fusion partners between the start codon and
he ﬁrst SapI site, replacing the 3C and decahistidine region.
For downstream applications, N-terminal afﬁnity and solubility
ags were made removable by the utility of speciﬁc proteases. A 3C
ite was designed to p2 and p7, identical to the design in p1 to allow
leavage by 3C protease (Cordingley et al., 1989). No linear motif
as added to p3 and p6, as the ubiquitin-like protease 1 (Ulp1)
peciﬁcally recognizes the tertiary structure of SUMO to remove
he tag (Mossessova and Lima, 2000).
Synthetic genes (GenScript) optimized for E. coli production
ncoding either the E. coli malE gene or the S. cerevisiae smt3 gene
erved as templates for megaprimer PCRs of MBP  (aa 27–391, Gen-
ank acc. no.: AIZ93193) and SUMO (aa 2–97, GenBank acc. no.:
2 Abbreviations: his, polyhistidine; MBP, maltose binding protein, SUMO, small
biquitin-related modiﬁer; FX-cloning, fragment exchange cloning; RF, restriction-
ree  cloning; EMP, exponential megapriming PCR; 3C, HRV 3C protease; Ulp1,
biquitin-like protease 1, FITC, ﬂuorescein isothiocyanate; HRP, horseradish per-
xidase; eGFP, enhanced green ﬂuorescent protein.placement and orientation of the SapI sites used in the FX-cloning procedure. Linear
sequence motifs are introduced to allow tag removal by 3C protease in p1, p2 and
p7  (black line), whereas the SUMO fusion in p3 and p6 can be removed by Ulp1
protease after tertiary structure recognition.
DAA12341), respectively, by exponential megapriming PCR cloning
(EMP, Ulrich et al., 2012). In brief, the megaprimers of genes encod-
ing MBP  and SUMO were ampliﬁed using Phusion polymerase
(NEB), puriﬁed with the QIAquick PCR puriﬁcation kit (Qiagen) and
inserted to vectors by linear (in case of p2 and p3) or exponen-
tial plasmid ampliﬁcation (in case of p6 and p7) and treated as
described in the protocols (Ulrich et al., 2012; van den Ent and Löwe,
2006). To remove parental DNA, the PCR products were digested
with 10U DpnI (NEB) and transformed into E. coli MC1061 cells.
Plasmids were isolated using the NucleoSpin plasmid puriﬁcation
kit (Macherey-Nagel). Sanger sequencing was used to conﬁrm cor-
rect cloning of all vectors. Primers for RF and EMP  cloning were
designed using an online tool (Bond and Naus, 2012). Information
on primers and vectors used in this study is summarized in Table
S1 and Table 1, respectively.
2.2. Molecular cloning of eGFP and subtilisins to vector suite
The pCMV cyto-EGFP-myc plasmid served as template for the
ampliﬁcation of a mutated gfp gene (egfp) encoding enhanced green
ﬂuorescent protein (eGFP, residues 2-239) (Cormack et al., 1996) by
Phusion PCR and primers in Table S1. The egfp gene was integrated
into the pINITIAL cloning vector (Table 1) by digesting the PCR prod-
uct and the vector with SapI (NEB) and ligating with T4 DNA ligase
(NEB) according to the fragment exchange (FX) cloning protocol
(Geertsma, 2014). The ligation reaction was transformed into E. coli
MC1061 cells and clones were selected on LB-agar (1% (w/v) tryp-
tone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 1.5% (w/v) agar-agar)
supplemented with kanamycin (50 g/ml, Sigma-Aldrich). Plas-
mids were isolated as above, and sequencing was  used to conﬁrm
correct cloning of all pINITIAL constructs. Sub-cloning from pINI-
TIAL to the expression vectors (Fig. 1) were carried out as outlined
40 G.E.K. Bjerga et al. / Journal of Biotechnology 222 (2016) 38–46
Table 1
Vectors used in this study.
Vector name Fusion partners His-tag
length (aa)
Fusion
partner
size (kDa)
Promoter Tag removala Resistance gene Vector type Reference
pINITIAL – – – – – cam Cloning Geertsma and
Dutzler (2011)
p1 (pBXNH3) N-his 10 2.6 pBAD 3C amp  Expression Geertsma and
Dutzler (2011)
p2 N-his-MBP 10 42.7 pBAD 3C amp  Expression This study
p3  N-his-SUMO 10 12.6 pBAD Ulp1 amp  Expression This study
p5  (pBXC3H) C-his 10 2.3 pBAD 3C amp  Expression Geertsma and
Dutzler (2011)
p12 C-his 6 0.8 pBAD – amp  Expression This study
p7  N-MBP, C-his 6 41.4 pBAD 3C amp  Expression This study
p6  N-SUMO, C-his 6 11.3 pBAD Ulp1 amp  Expression This study
pUC57:smt3  (S2-G97)-opt (smt3 template) – – – – kan Cloning This study
pUC57:His-malE(K27-Q391)
3C-opt
(malE  template) – – – – kan Cloning This study
re rem
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SpUC57.kan, SapI-free – – – – 
a For p6 and p7 the N-terminal fusion partners, but not the C-terminal his tags, a
bove, except that clones were selected on LB agar with ampicillin
100 g/ml, Sigma-Aldrich).
Codon-optimized apr genes (GenScript) encoding Bacilli sub-
ilisins (Table 2) ﬂanked by SapI sites served as templates for FX
loning of full-length genes to expression vectors, or served as tem-
lates for PCRs in the case of truncated genes. Otherwise, genes
ere cloned as described above. Empty vectors were generated
y replacing the ccdB gene with a GSGSGS linker to allow their
loning and expression in E. coli MC1061 cells. The GSGSGS-linker
as constructed by hybridizing two oligos to one double stranded
NA fragment designed to contain sticky SapI overhangs to allow
ts integration to the pINITIAL vector. Information on primers used
s summarized in Table S1.
.3. Site-directed mutagenesis
A Phusion PCR using mutagenesis primers (Table S1) was
esigned to generate a S325A mutation in the apr gene of B. licheni-
ormis DSM13 in pINITIAL. Parental DNA was removed by DpnI
igestion. Mutants were then transformed into E. coli MC1061 and
elected to LB agar containing 34 g/ml chloramphenicol (Sigma-
ldrich). The mutant subtilisin was sub-cloned to the expression
ector suite as described above.
.4. Recombinant expressionRecombinant expression was carried out according to a protocol
escribed elsewhere (Vincentelli et al., 2011). The E. coli MC1061
train was utilized for expression due to its inability to metabolize
able 2
ubtilisins used in this study.
Origin (short
name)
Enzyme name GenBank acc. no. ATCC reference Re
(pr
Bacillus
licheniformis
DSM13 (Bli)
Subtilisin Carlsberg
AprE
AAU40017 14580 Jac
Bacillus
paralicheniformis
ATCC  9945a (Bpa)
Subtilisin Carlsberg
AprE
AGN35600 9945a Jac
Bacillus subtilis
subsp. subtilis str.
168 (Bsu)
SubtilisinE CAB12870 23857 Sta
(19
Bacillus
amyloliquefaciens
ATCC  23844 (Bam)
BPN’ subtilisin AAB05345 23844 Va
(19– kan Cloning GenScript
ovable.
the inducer, L-arabinose. Precultures in LB media were inoculated
directly from positive clones on LB agar with 100 g/ml ampicillin
and grown 16–20 h at 250 rpm at 37 ◦C. In deep 24-well plates, 4 ml
2YT media (1.6% (w/v) tryptone, 1% (w/v) yeast extract and 0.5%
(w/v) NaCl) containing 100 g/ml ampicillin was inoculated with
100 l precultures and incubated at 37 ◦C at 250 rpm for 2 h to reach
log phase. Cultures were equilibrated to 20 ◦C for 30 min  before
induction of the pBAD promoter with 0.1% (v/v) L-arabinose (Sigma-
Aldrich) for 16–20 h at 250 rpm at 20 ◦C. To improve the protocol,
cultures can also be autoinduced by replacing lactose with arabi-
nose in a trace-metal free version of the ZYP-5052 media (Studier,
2005). 100 l culture was used for OD measurements by reading
absorbance at 600 nm using the Hidex Sense microplate reader
(Kem-En-Tec Nordic). The cells were harvested using an Allegra X-
12R benchtop centrifuge (Beckman Coulter) at 4750 rpm for 15 min.
Cells were resuspended in 1 ml  8.5 N lysis buffer (50 mM Tris HCl
pH 8.5, 50 mM NaCl, 0.25 mg/ml  lysozyme, 10% (v/v) glycerol), and
incubated at 20 min  at room temperature during gentle agitation
for lysis. Lysis was completed by ultrasound using ﬁve seconds
pulse two times at 40–60% amplitude with a CV-18 probe pow-
ered by an Ultrasonic Homogenizer 4710 (Cole Parmer). Lysates
were cleared by centrifugation at 4750 rpm for 15 min. Cleared
lysate samples (representing soluble fraction) were analysed by
SDS-PAGE (Laemmli, 1970).2.5. Immunoblot
Proteins from cleared lysates were analysed by SDS-PAGE, and
transferred onto a nitrocellulose membrane (Towbin et al., 1979)
ference
otease)
Reference
(genome)
Length (aa) Sequence identity
to B. licheniformis
DSM13 (%).
obs et al. (1985) Rey et al. (2004) 379 100
obs et al. (1985) Rachinger et al.
(2013)
379 98.2
hl and Ferrari
84)
Kunst et al. (1997) 381 66.1
santha et al.
84)
– 382 66.1
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Fig. 2. Recombinant expression of eGFP in the vector suite.
A.  Fluorescence from cultures containing eGFP in six different fusion constructs. Fluorescence was  normalized to the optical density of the bacterial cultures. Expression from
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y  SDS-PAGE. Sizes of molecular weight standard (M)  are shown to the right (in kD
sing the Trans-Blot Turbo (BioRad) transfer system. A mouse mon-
clonal anti-polyhistidine antibody (H1029, Sigma-Aldrich) and
 mouse monoclonal anti-MBP antibody (M1321, Sigma-Aldrich)
ere used to detect recombinant expression of subtilisin mutants.
he primary antibodies were detected with a secondary rabbit HRP-
inked mouse IgG (NA931 V, GE Healtcare). The HRP-reaction was
eveloped with the Clarity Western ECL Substrate (BioRad), and
maged in the Chemi-Doc gel imager (BioRad).
.6. eGFP ﬂuorescence measurement
Upon harvest, 100 l culture from eGFP expression was  used for
D measurements by reading the absorbance at 600 nm using the
luoStar Optima microplate reader (BMG Labtech). Fluorescence
rom cell cultures was measured at excitation 485 nm and emis-
ion 520 nm,  and values were normalized to optical density of the
acterial cultures to compensate for growth differences.
.7. Casein-based protease assay
The protease ﬂuorescent detection kit (PF0100, Sigma-Aldrich)
as used for detection of proteolytic activity (Twining, 1984). 5 l
leared lysates were used in activity assays with 10 l FITC-labelled
asein and adjusted to 25 l with 20 mM phosphate buffer pH 7.6,
nd incubated at 60 ◦C for 1 h. Unhydrolyzed proteins were precip-
tated by 75 l 0.6 N Trichloroacetic Acid (TCA) at 37 ◦C for 30 min.
ydrolyzed FITC-peptides were then collected by centrifugation
n a Heraeus Pico centrifuge (Thermo Scientiﬁc) at 13.000 rpm for
–10 min. 2 l supernatant was added to 200 l 0.5 M TrisHCl pH
.5 in MicroFluor 1 plates (Thermo Scientiﬁc) and ﬂuorescence
as measured at excitation 485 nm and emission 520 nm using
he Hidex Sense microplate reader. As a control, Alcalase ®2.4 L
P4860, Sigma-Aldrich) was used at a dilution 1:50 000 in lysis
uffer.ifferent constructs. B. Analysis of protein integrity of soluble eGFP fusion proteins
erisks indicate the expected mass of the recombinant proteins.
3. Results and discussion
3.1. Screening procedure design and vector suite validation
Our aim was  to develop a quick but robust screening procedure
for subtilisin-like proteases. We identiﬁed a set of design require-
ments for such a screening procedure: the entire procedure should
be compatible with a plate format for high throughput; expression
should be carried out in the cytoplasm of E. coli for high yield; the
cloning system should facilitate simple, parallel sub-cloning into a
set of vectors for exploitation of puriﬁcation and solubility tags; and
ﬁnally, a functional screen should be implemented for assessment
of activity from recombinant proteases in lysates. A recently devel-
oped vector suite, which facilitates sub-cloning based on fragment
exchange (FX) of the gene of interest from a cloning vector into mul-
tiple expression vectors, was  chosen as a starting point (Geertsma
and Dutzler, 2011). The approach is highly effective due to the direc-
tional cloning caused by the orientation of the type IIS restriction
sites (SapI) and the presence of counter selection genes. Based on
available vectors (p1 and p5, Table 1), we constructed ﬁve new ones,
p2, p3, p6, p7 and p12 (Fig. 1, Table 1), designed to express serine
proteases in fusion to selected afﬁnity and solubility tags. We chose
to include two solubility tags for use in N-terminal fusions, namely
MBP  (Kapust and Waugh, 1999) and SUMO (Malakhov et al., 2004).
In case the tags would interfere with maturation and/or proteolytic
activity, speciﬁc protease sites were included for tag removal (3C
and Ulp1 proteases, respectively). All constructs contained either
an N-terminal or C-terminal his-tag to enable detection and protein
puriﬁcation. The C-terminal his-tag containing vectors were con-
structed to allow puriﬁcation of mature protease (Ghasemi et al.,
2012; Hu et al., 2013; Sroga and Dordick, 2002). Cloning was scaled
to a plate-based format that allowed parallel cloning of many con-
structs simultaneously.To validate the expression vectors, we chose the gene encod-
ing eGFP for simple ﬂuorescence-based monitoring of recombinant
protein production. The egfp gene was  cloned into the pINITIAL
cloning vector, veriﬁed by sequencing, and sub-cloned into our
42 G.E.K. Bjerga et al. / Journal of Biotechnology 222 (2016) 38–46
Fig. 3. Activity of recombinant B. licheniformis DSM13 pro-subtilisin in E. coli.
A. Cartoon of the annotated B. licheniformis DSM13 subtilisin with leader sequence (square-shaped box), proteolytic cleavage positions (arrows), catalytic triad
(open  rings) and Pfam domain annotations (PF-coded oval-shaped box). Below the constructs used in this study are shown: the full-length pre-pro subtil-
isin  sequence (residues 1-379, C1), the pro-subtilisin construct (residues 30-379, C2), and the mature subtilisin (residues 106-379, C3). Cartoon is drawn to
scale.  B. The soluble fraction of extracts containing subtilisin constructs (C1-C3) in three vectors, p1, p2 or p3, were screened for proteolytic activity against
FITC-conjugated casein. Fluorescence was normalized to optical density of expression cultures, to account for growth effects. Expression from empty vectors
was  used as a control. Error bars represent standard deviation between two independent experiments. C. Analysis of protein integrity of native pro-subtilisin
and  the catalytic S325A mutant by SDS-PAGE (upper panel) and immunoblots (IB). Antibodies against the his-tag (middle panel) and the MBP  tag (lower panel)
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anel of expression vectors. Next, the vectors were used to express
he eGFP fusion proteins in E. coli MC1061, and the expression cul-
ures were monitored directly for in vivo ﬂuorescence (Fig. 2A)
such as applied in Scholz et al., 2013). The N-terminally his-tagged
GFP construct (p1) had a much higher level of ﬂuorescence than
he one with a C-terminal his-tag (p12), which ﬂuoresced just
bove background. Both the N- and C-terminally his-tagged con-
tructs displayed increased ﬂuorescence when fused to either MBP
r SUMO (Fig. 2A). Protein expression levels in the soluble fraction
orrelated well with the in vivo ﬂuorescence data (Fig. 2B), sug-
esting that the differences in ﬂuorescence were due to different
mounts of soluble protein. These results validated the integrity
f the vectors, and demonstrated that the MBP  and SUMO tags
ncreased the solubility of the target protein, in line with previous
ata (Marblestone et al., 2006).
.2. Validation of the screening procedure using four Bacillus
ubtilisins
To validate the suitability of the vector suite for expression of
erine proteases, the industrially relevant subtilisin from Bacillus
icheniformis (trade name: Alcalase 2.4 L, NovozymesTM) was cho-
en as a reference protease. As periplasmic expression of subtilisin
n E. coli has shown low expression levels (Ikemura and Inouye,
988; Ikemura et al., 1987), we decided to attempt cytoplasmic
xpression (e.g. Hu et al., 2013; Maciver et al., 1994; Zhang et al.,
005).
To investigate whether expressing the full-length or other trun-
ated versions of the apr gene would affect solubility and activity,
e cloned three versions of the gene of the Bacillus licheniformis
SM13 apr into the p1, p2, and p3 vectors (Fig. 3A). The ﬁrst con-
truct contained the entire apr gene, encoding pre-pro subtilisin
residues 1-379, C1). The second construct contained a truncated
ene encoding pro-subtilisin (residues 30-379, C2) without the
eader sequence. The third construct contained a truncated gene
here the part encoding both the pre and pro sequences was
emoved (residues 106-379, C3). All gene versions were codon-
ptimized to improve protein expression. The three apr gene
ariants were cloned into pINITIAL, sub-cloned into the three
xpression vectors, and expressed in the E. coli MC1061 strain.
To measure the activity of the expressed subtilisin fusions, we
hose an in vitro casein-based protease assay (Twining, 1984). In
his assay, the use of ﬂuorescein isothiocyanate (FITC) conjugated
asein allows direct screens for protease activity in the cleared
xtracts, thus eliminating elaborate puriﬁcation steps. Casein was
hosen to facilitate screening for proteases with broad speciﬁcity
or peptide bonds. The soluble extracts containing subtilisin fusions
ere tested in the assay, and compared to extracts from strains car-
ying empty plasmid vectors (Fig. 3B). The negative controls using
mpty vectors did not exhibit any activity, which suggests that the
ctivity observed in the extracts containing subtilisin fusion was
ot due to E. coli host proteases. Hence, the proteolytic degradation
f FITC-casein in those extracts is likely caused by the activity of
he expressed native subtilisin fusions. Cultures expressing the C2
ersion were shown to be the optimal construct (Fig. 3B). The C1
ersion showed signiﬁcant growth deﬁciencies, which may  suggest
hat the subtilisin leader sequence caused misfolding. Despite this,
ome activity was observed with soluble extracts containing C1 in
he FITC-casein assay. In contrast, soluble extracts containing the
3 construct showed no activity. In line with previous data, these
ere used to identify the recombinant mutant constructs. Sizes of molecular weight stand
nprocessed recombinant proteins. The mature subtilisin is 27 kDa D. FITC-casein activity
.  licheniformis DSM13 and the catalytic S325A mutant. Hydrolysis was  measured as in B,
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results strongly suggest that putative leader sequences should be
removed when screening for new subtilisins using our system, but
that the pro sequence should be kept intact (Ikemura et al., 1987;
Ohta et al., 1991; Zhu et al., 1989).
It was not obvious that N-terminal fusion tags would promote
correct folding of subtilisin, as these might hinder folding assisted
by the pro domain. The highest activity was, however, observed
with the extracts containing the N-terminal his-SUMO (p2) and his-
MBP  (p3) fusion constructs of the C2 version of subtilisin (Fig. 3B).
These results show that fusion to a large solubility partner at the
N-terminal of pro-subtilisin promoted production of active serine
proteases. Our data is in line with previous data obtained with MBP
(Kwon et al., 2011; Sakaguchi et al., 2008). To our knowledge, this is
the ﬁrst time subtilisin has been successfully expressed as a SUMO
fusion protein in E. coli.
As a C-terminal his-tag may  allow downstream puriﬁcation
and detection after maturation, the C2 subtilisin construct was
also cloned to the p6, p7 and p12 vectors. As an additional neg-
ative control, we constructed a mutant of the truncated apr gene
where the codon for the nucleophilic serine S325 in the catalytic
triad was mutated to an alanine codon (Fig. 1) (Carter and Wells,
1988). The soluble fractions of sonicated cells were analysed by
SDS-PAGE, revealing striking differences in the observed protein
patterns of the native subtilisin fusion proteins and their cognate
mutant controls (Fig. 3C). The lack of high molecular weight pro-
teins in the native subtilisin-containing fractions suggests that they
are expressed and have proteolytic activity. However, there were
no visible protein bands corresponding to the native subtilisin
fusion proteins, and mass spectrometry (MS) analysis of the sam-
ples also failed to identify them. Instead, the MS  analysis revealed
the presence of known protease resistant E. coli membrane and
periplasmic proteins (Table S2). In contrast to the native subtilisin
fusion proteins, most of the mutant subtilisins, with the exception
of the p12 mutant construct, were identiﬁed, either directly on the
Coomassie-stained SDS-PAGE, or by immunoblotting using anti-his
and anti-MBP antibodies (Fig. 3C). Overall, this suggests that the
subtilisin fusion proteins are expressed, soluble and active.
All subtilisin fusion proteins were able to digest FITC-casein
(Fig. 3D), but again the highest activity was observed with the
extracts containing the N-terminal his-SUMO and his-MBP fusion
constructs. Interestingly, the conventional subtilisin construct
design with a C-terminal his-tag (p12) was  the second lowest
performing construct in the activity assay. The extent of hydrol-
ysis observed by the SDS-PAGE analysis (Fig. 3C) correlated with
the level of proteolytic activity observed in the FITC-casein assay
(Fig. 3D).
Furthermore, there is a striking similarity to the eGFP validation
experiment (Fig. 2); the effect of the different fusion constructs
on the levels of ﬂuorescence in the eGFP experiment is similar to
the activities observed with the subtilisin fusion proteins (Fig. 3D).
This suggests that the vector suite may  have some generic features,
and that its utility is not restricted to proteases. To conclude, the
described E. coli based expression system was used to successfully
express soluble B. licheniformis DSM13 subtilisin fusion proteins,
which were active in the casein-based activity assay.
As a ﬁnal validation step of our screening procedure, we per-
formed a mini screen of the B. licheniformis DSM13 apr gene and
three other Bacilli genes from B. paralicheniformis ATCC 9945a, B.
amyloliquefaciens ATCC 23844 and B. subtilis subsp.  subtilis str. 168
(Table 2). The subtilisins encoded by these genes are thermophilic
ard (M)  are shown to the right (in kDa). Asterisks indicate the expected mass of the
 of soluble E. coli extracts containing fusion constructs of native pro-subtilisin from
 except error bars show standard deviation in two replicates in one representative
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Fig. 4. Proteolytic activity of four Bacilli subtilisin homologues.
T ologous subtilisins were screened for proteolytic activity against FITC-conjugated casein.
H  two  replicates in one representative experiment. Bli, Bacillus licheniformis DSM13; Bpa,
B m, Bacillus amyloliquefaciens ATCC 23844.
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Fig. 5. A ﬂow-chart of the rapid, solubility-optimized screening procedure for
recombinant subtilisins in E. coli.
The procedure has been developed and tailored to subtilisins, and enables a four-
day approach succeeding from sub-cloning of candidate genes in expression vectors
to  the evaluation of enzymatic activity. The screening-approach utilizes a rapid andhe soluble fractions of E. coli extracts containing fusion constructs of the four hom
ydrolysis was  measured as in Fig. 3, where error bars show standard deviation in
acillus paralicheniformis ATCC 9945a;  Bsu, Bacillus subtilis subsp.  subtilis str. 168; Ba
ith temperature optimums above 40 ◦C (Table 2) (examples in
erreira et al., 2003; Peng et al., 2003; Sellami-Kamoun et al.,
008), and their pairwise sequence identities range from 66 to
8% (Table 2). The three additional apr genes, without the leader
equence encoding part, were cloned into the six expression vec-
ors. Each of the four subtilisins was expressed from the six
xpression plasmids, and soluble extracts were tested for pro-
ease activity using the FITC-casein assay (Fig. 4). All four subtilisin
argets were positively identiﬁed as active proteases in four or
ve of the constructs, using three times the background signal
o determine the threshold. The two constructs that showed the
ost consistent activity across the different subtilisins were the
is-MBP (p2) and his-SUMO fusions (p3). This suggests that one
ould restrict future screens for new subtilisins to only the p2 and
3 vectors, thus increasing the throughput of the system. How-
ver, the high activity of the p12 construct of B. amyloliquefaciens
TCC 23844 subtilisin (Fig. 4) demonstrates the merit of including
dditional vectors in the screen, as the C-terminal his tag allows
or downstream puriﬁcation and characterization. This construct
lso indicates that the success of recombinant expression from a
articular vector may  be protein-dependent, and that a range of
xpression vehicles with different properties may  be valuable to
dentify positive candidates.
. Conclusion
The development of a screening procedure for the identiﬁca-
ion of recombinant subtilisins has been described. The overall
rocedure enables a four-day approach from the sub-cloning of
andidate genes in expression vectors to the evaluation of enzy-
atic activity (Fig. 5). The approach utilizes a rapid cloning method
or sub-cloning of genes into six expression vectors and subsequent
ecombinant expression in E. coli MC1061, an ultrasound-based
ell lysis and direct activity assessment of soluble fractions with
ITC-casein. The screening approach has been validated using four
omologous Bacilli apr encoded subtilisins of varying degree of
equence identities (ranging from 65 to 98%) and temperature
roﬁles (ranging roughly 40–80 ◦C). All subtilisins were identi-versatile FX-cloning regime, subsequent recombinant production in E. coli MC1061,
an  ultrasound-based cell lysis and activity assaying with FITC-casein.
ﬁed as active proteases in at least four of the constructs. Hence,
this approach is suitable for application in discovery of novel
subtilisin-like proteases or for application on engineered subtilisin-
like proteases (Bryan, 2000; Wells and Estell, 1988) to effectively
screen production of mutants and their enzymatic activity. We
also showed, using eGFP, that the utility of the vector suite is not
restricted to proteases. Other applications may, however, require
tailoring to the speciﬁc type of protein, depending on their proper-
ties, such as metal-requirement, temperature and pH range.
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